132 related articles for article (PubMed ID: 16896016)
21. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus.
Steiner G
Am J Cardiol; 2008 Dec; 102(12A):28L-33L. PubMed ID: 19084087
[TBL] [Abstract][Full Text] [Related]
22. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study.
Lucove J; Vupputuri S; Heiss G; North K; Russell M
Am J Kidney Dis; 2008 Jan; 51(1):21-8. PubMed ID: 18155529
[TBL] [Abstract][Full Text] [Related]
23. Thailand diabetes registry project: current status of dyslipidemia in Thai diabetic patients.
Pratipanawatr T; Rawdaree P; Chetthakul T; Bunnag P; Ngarmukos C; Benjasuratwong Y; Leelawatana R; Kosachunhanun N; Plengvidhya N; Deerochanawong C; Suwanwalaikorn S; Krittiyawong S; Mongkolsomlit S; Komoltri C
J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S60-5. PubMed ID: 17715835
[TBL] [Abstract][Full Text] [Related]
24. Metabolic syndrome: are we at risk?
Paudel B
Nepal Med Coll J; 2007 Sep; 9(3):204-11. PubMed ID: 18092442
[TBL] [Abstract][Full Text] [Related]
25. OMEGA study: design, baseline data, metabolic syndrome prevalence in a large-scale observational study of hypertensive patients: The Olmesartan Mega Study to Determine the Relationship between Cardiovascular Endpoints and Blood Pressure Goal Achievement study.
Teramoto T; Fujita T; Kawamori R; Miyazaki S; Teramukai S; Igarashi M
Hypertens Res; 2008 Nov; 31(11):2011-7. PubMed ID: 19098372
[TBL] [Abstract][Full Text] [Related]
26. The metabolic syndrome: prevalence, CHD risk, and treatment.
Sarti C; Gallagher J
J Diabetes Complications; 2006; 20(2):121-32. PubMed ID: 16504841
[TBL] [Abstract][Full Text] [Related]
27. The management of type 2 diabetes in children and adolescents.
Daaboul JJ; Siverstein JH
Minerva Pediatr; 2004 Jun; 56(3):255-64. PubMed ID: 15252375
[TBL] [Abstract][Full Text] [Related]
28. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus.
Rubin RR
Am J Med; 2005 May; 118 Suppl 5A():27S-34S. PubMed ID: 15850551
[TBL] [Abstract][Full Text] [Related]
29. The prevalence of the metabolic syndrome and type 2 diabetes mellitus in children and adolescents.
Molnár D
Int J Obes Relat Metab Disord; 2004 Nov; 28 Suppl 3():S70-4. PubMed ID: 15543223
[TBL] [Abstract][Full Text] [Related]
30. Prevention of stroke in patients with diabetes mellitus and the metabolic syndrome.
Rothwell PM
Cerebrovasc Dis; 2005; 20 Suppl 1():24-34. PubMed ID: 16276082
[TBL] [Abstract][Full Text] [Related]
31. Nutraceuticals in diabetes and metabolic syndrome.
Davì G; Santilli F; Patrono C
Cardiovasc Ther; 2010 Aug; 28(4):216-26. PubMed ID: 20633024
[TBL] [Abstract][Full Text] [Related]
32. Type 2 diabetes mellitus among youth in Puerto Rico, 2003.
Pérez-Perdomo R; Pérez-Cardona CM; Allende-Vigo M; Rivera-Rodríguez MI; Rodríguez-Lugo LA
P R Health Sci J; 2005 Jun; 24(2):111-7. PubMed ID: 16116927
[TBL] [Abstract][Full Text] [Related]
33. Schizophrenia, the metabolic syndrome and diabetes.
Holt RI; Peveler RC; Byrne CD
Diabet Med; 2004 Jun; 21(6):515-23. PubMed ID: 15154933
[TBL] [Abstract][Full Text] [Related]
34. Regarding "prevalence of the metabolic syndrome in relation to self-reported cancer history".
Polednak AP
Ann Epidemiol; 2006 Dec; 16(12):877-9. PubMed ID: 16882474
[No Abstract] [Full Text] [Related]
35. [Emergence of type 2 diabetes in French children].
Czernichow P; Tubiana-Rufi N
Bull Acad Natl Med; 2004; 188(8):1443-51; discussion 1451-3. PubMed ID: 15918670
[TBL] [Abstract][Full Text] [Related]
36. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome.
Worm SW; Friis-Møller N; Bruyand M; D'Arminio Monforte A; Rickenbach M; Reiss P; El-Sadr W; Phillips A; Lundgren J; Sabin C;
AIDS; 2010 Jan; 24(3):427-35. PubMed ID: 19910787
[TBL] [Abstract][Full Text] [Related]
37. [Diabetes 2: it is possible to prevent it].
Rubin P
Servir; 2004; 52(5):251-4. PubMed ID: 15600064
[No Abstract] [Full Text] [Related]
38. Management of the metabolic syndrome-nicotinic acid.
Meyers CD; Kashyap ML
Endocrinol Metab Clin North Am; 2004 Sep; 33(3):557-75, vii. PubMed ID: 15262297
[TBL] [Abstract][Full Text] [Related]
39. [Type 2 diabetes in children and adolescents].
Poulsen MK; Jacobsen BB
Ugeskr Laeger; 2005 Jan; 167(5):489-93. PubMed ID: 15745167
[No Abstract] [Full Text] [Related]
40. Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome.
Isaacsohn JL; Troendle AJ; Orloff DG
Am J Cardiol; 2004 Jun; 93(11A):49C-52C. PubMed ID: 15178516
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
